ESCAPE Bio Company
ESCAPE Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat neurodegenerative diseases.
Estimated Revenue:
$10M to $50M
Industry:
Biotechnology, Health Care, Medical
Investors Number:
14
Last Funding Date:
2020
Founded Date:
2015
Headquarters:
South San Francisco, California, United States
Total Funding:
187076080
Last Funding Type:
Venture - Series Unknown
Employee Number:
11-50